<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Recall Lawsuit &#187; Medical</title>
	<atom:link href="http://www.recalllawsuit.com/category/medical-product-recall/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.recalllawsuit.com</link>
	<description>Recall and Lawsuit News and Information</description>
	<lastBuildDate>Sat, 04 Sep 2010 03:52:33 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.1</generator>
		<item>
		<title>Children&#8217;s Tylenol, Motrin, Benadryl and Zyrtec Recalled</title>
		<link>http://www.recalllawsuit.com/2010/05/childrens-tylenol-motrin-benadryl-and-zyrtec-recalled/</link>
		<comments>http://www.recalllawsuit.com/2010/05/childrens-tylenol-motrin-benadryl-and-zyrtec-recalled/#comments</comments>
		<pubDate>Mon, 03 May 2010 16:51:19 +0000</pubDate>
		<dc:creator>Elliot Olsen</dc:creator>
				<category><![CDATA[4 Feature Area]]></category>
		<category><![CDATA[Children's Products]]></category>
		<category><![CDATA[Main Feature Area]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Medicine]]></category>
		<category><![CDATA[child medicine recall]]></category>
		<category><![CDATA[defective childrens product]]></category>

		<guid isPermaLink="false">http://www.recalllawsuit.com/?p=760</guid>
		<description><![CDATA[<p>A children&#8217;s drug recall includes Tylenol, Motrin, Zyrtec and Benadryl recalled by McNeil Consumer Healthcare, a unit of Johnson &#38; Johnson, according to<a href="http://www.fda.gov/Safety/Recalls/ucm210443.htm"> a U.S. Food and Drug Administration announcement</a>. Some products may contain particles, the <em>New York Times</em>&#8230;</p>]]></description>
			<content:encoded><![CDATA[<p>A children&#8217;s drug recall includes Tylenol, Motrin, Zyrtec and Benadryl recalled by McNeil Consumer Healthcare, a unit of Johnson &amp; Johnson, according to<a href="http://www.fda.gov/Safety/Recalls/ucm210443.htm"> a U.S. Food and Drug Administration announcement</a>. Some products may contain particles, the <em>New York Times</em> <a href="http://www.nytimes.com/2010/05/02/business/02drug.html?scp=3&amp;sq=tylenol%20recall&amp;st=cse">reported</a>. “The particles may be solidified product ingredients or manufacturing residue such as tiny metal specks,” Marc Boston, a McNeil spokesman, told the <em>Times</em>.</p>
<p><a href="http://www.recalllawsuit.com/wp-content/uploads/iStock_kidsLiquidMeds.jpg"><img class="aligncenter size-medium wp-image-761" title="iStock_kidsLiquidMeds" src="http://www.recalllawsuit.com/wp-content/uploads/iStock_kidsLiquidMeds-300x199.jpg" alt="children's medicine recall" width="300" height="199" /></a></p>
<p>The recall involves seven products in 43 different flavors and sizes, including:</p>
<ul>
<li>Tylenol Infants’ Drops</li>
<li>Children’s Tylenol Suspensions</li>
<li>Infants’ Motrin Drops</li>
<li>Children’s Zyrtec liquids in bottles</li>
<li>Children’s Benadryl Allergy liquids</li>
</ul>
<p>The recall is being initiated &#8220;due to manufacturing deficiencies which may affect quality, purity or potency,&#8221; according to an FDA announcement. In the same statement, FDA officials commented on the recall:</p>
<blockquote><p>“We want to be certain that consumers discontinue using these products and that they know what to do if they have concerns about a specific product,” said Commissioner of Food and Drugs Margaret A. Hamburg, M.D. “While the potential for serious health problems is remote, Americans deserve medications that are safe, effective and of the highest quality. We are investigating the products and facilities associated with this recall and will provide updates as we learn more.”</p></blockquote>
<p><a href="http://www.pritzkerlaw.com/child-safety-lawyer/">Pritzker Olsen child safety attorneys</a> have represented the families of children who have been seriously injured or even killed by <a href="http://www.pritzkerlaw.com/child-safety-lawyer/defective-childrens-products.html">defective children&#8217;s products</a>. It takes lawyers with extensive experience in <a href="http://www.pritzkerlaw.com/defective-product-lawyers/">product liability lawsuits</a> to obtain the maximum amount of monetary damages that victims and their families deserve. While we understand that no amount of money can undo the suffering a child and his or her family may experience due to a defective product, monetary damages can ease families&#8217; burdens by covering medical or funeral expenses.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.recalllawsuit.com/2010/05/childrens-tylenol-motrin-benadryl-and-zyrtec-recalled/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Camolyn and Fisiolin Eye and Nasal Drop Recall Over Infection Fears</title>
		<link>http://www.recalllawsuit.com/2010/04/camolyn-and-fisiolin-eye-and-nasal-drop-recall-over-infection-fears/</link>
		<comments>http://www.recalllawsuit.com/2010/04/camolyn-and-fisiolin-eye-and-nasal-drop-recall-over-infection-fears/#comments</comments>
		<pubDate>Fri, 09 Apr 2010 16:58:12 +0000</pubDate>
		<dc:creator>Elliot Olsen</dc:creator>
				<category><![CDATA[4 Feature Area]]></category>
		<category><![CDATA[Main Feature Area]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[eye drop infection lawsuit]]></category>

		<guid isPermaLink="false">http://www.recalllawsuit.com/?p=716</guid>
		<description><![CDATA[<p>A Camolyn eye drop and Fisiolin nasal drop recall has been issued by US Oftalmi, of Hallandale, Florida because the products may not be sterile, <a href="http://www.fda.gov/Safety/Recalls/ucm207735.htm">according to the U.S. Food and Drud Administration (FDA)</a>.</p>
<p><a href="http://www.recalllawsuit.com/wp-content/uploads/iStock_eyedrops.jpg"><img class="aligncenter size-medium wp-image-718" title="iStock_eyedrops" src="http://www.recalllawsuit.com/wp-content/uploads/iStock_eyedrops-300x199.jpg" alt="eyedrop infection" width="300" height="199" /></a></p>
<p>The company is recalling&#8230;</p>]]></description>
			<content:encoded><![CDATA[<p>A Camolyn eye drop and Fisiolin nasal drop recall has been issued by US Oftalmi, of Hallandale, Florida because the products may not be sterile, <a href="http://www.fda.gov/Safety/Recalls/ucm207735.htm">according to the U.S. Food and Drud Administration (FDA)</a>.</p>
<p><a href="http://www.recalllawsuit.com/wp-content/uploads/iStock_eyedrops.jpg"><img class="aligncenter size-medium wp-image-718" title="iStock_eyedrops" src="http://www.recalllawsuit.com/wp-content/uploads/iStock_eyedrops-300x199.jpg" alt="eyedrop infection" width="300" height="199" /></a></p>
<p>The company is recalling 15mL plastic bottles of Camolyn eye drops and Fisiolin nasal drops that were distributed to food and drug retailers nationwide. The products may non-sterile due to manufacturing conditions. &#8220;Products that are non-sterile have the potential to cause eye infections, which may be sight threatening,&#8221; according to the FDA announcement. The recalled products are as follows:</p>
<table border="1" cellspacing="0" cellpadding="0" width="40%" summary="product details">
<tbody>
<tr>
<th id="header1" scope="col">PRODUCT</th>
<th id="header2" scope="col">LOT#</th>
<th id="header3" scope="col">EXPIRATION</p>
<p>DATE</th>
<th id="header4" scope="col">UPC</th>
</tr>
<tr>
<td>CAMOLYN HOMEOPATHIC</td>
<td>049036</p>
<p>087934</td>
<td>05/2011</p>
<p>08/2009</td>
<td>591196 00446</td>
</tr>
<tr>
<td>CAMOLYN PLUS, NAPHAZOLINE +</p>
<p>CHAMOMILE 15 ml.</td>
<td>037691</p>
<p>097420</td>
<td>03/2010</p>
<p>10/2010</td>
<td>66482 00018</td>
</tr>
<tr>
<td>CAMOLYN REFRESH 15 ml.</td>
<td>116636</p>
<p>107610</td>
<td>11/2009</p>
<p>11/2010</td>
<td>66482 00020</td>
</tr>
<tr>
<td>CAMOLYN-A, NAPHAZOLINE +</p>
<p>PHENIRAMINE 15 ml</td>
<td>057063</p>
<p>058962</p>
<p>106606</p>
<p>099487</td>
<td>05/2009</p>
<p>04/2010</p>
<p>10/2008</p>
<p>09/2011</td>
<td>66482 00019</td>
</tr>
<tr>
<td>FISIOLIN NASAL DROPS SODIUM</p>
<p>CHLORIDE PEDIATRIC USES 15 ml.</td>
<td>028659</td>
<td>03/2011</td>
<td>591196 00375</td>
</tr>
</tbody>
</table>
<p>The company has stopped producing, importing and distributing the product.</p>
<h2><em>Defective Medical Products Recall Information</em></h2>
<p>Pritzker Olsen attorneys have recovered millions for victims who have been injured by defective medications and medical products.</p>
<ul>
<li>Consumers should never use <a href="http://www.pritzkerlaw.com/Defective_Medical_Devices/">recalled defective medical products</a>.</li>
<li>Consumers injured by defective medical products may have a claim against manufacturers for economic damages, non-economic damages and punitive damages.</li>
</ul>
]]></content:encoded>
			<wfw:commentRss>http://www.recalllawsuit.com/2010/04/camolyn-and-fisiolin-eye-and-nasal-drop-recall-over-infection-fears/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Addresses Increased Insulin Pump Recalls</title>
		<link>http://www.recalllawsuit.com/2010/03/fda-addresses-increased-insulin-pump-recalls/</link>
		<comments>http://www.recalllawsuit.com/2010/03/fda-addresses-increased-insulin-pump-recalls/#comments</comments>
		<pubDate>Wed, 31 Mar 2010 23:36:10 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[4 Feature Area]]></category>
		<category><![CDATA[Main Feature Area]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[insulin pump lawsuit]]></category>
		<category><![CDATA[Medical device recall]]></category>
		<category><![CDATA[Medtronic lawsuit]]></category>

		<guid isPermaLink="false">http://www.recalllawsuit.com/?p=691</guid>
		<description><![CDATA[<p>The U.S. Food and Drug Administration held an advisory panel <a href="http://www.fda.gov/AdvisoryCommittees/Calendar/ucm197157.htm">meeting on insulin pumps </a>earlier this month to &#8220;make recommendations regarding clinical risks and benefits of post-market actions in response to insulin pump failures.&#8221; Reports from the FDA noted&#8230;</p>]]></description>
			<content:encoded><![CDATA[<p>The U.S. Food and Drug Administration held an advisory panel <a href="http://www.fda.gov/AdvisoryCommittees/Calendar/ucm197157.htm">meeting on insulin pumps </a>earlier this month to &#8220;make recommendations regarding clinical risks and benefits of post-market actions in response to insulin pump failures.&#8221; Reports from the FDA noted 18 insulin pump recalls  on its list of <a href="http://www.pritzkerlaw.com/FDA_Recalls/">medical product recalls</a> over a period of  five years, according to the <em><a href="http://blogs.wsj.com/health/2010/03/03/fda-finds-problems-with-insulin-pumps-across-manufacturers/?KEYWORDS=insulin+pumps">Wall Street Journal</a></em>.</p>
<p><a href="http://www.recalllawsuit.com/wp-content/uploads/iStock_insulin-pump.jpg"><img class="aligncenter size-medium wp-image-693" title="iStock_insulin pump" src="http://www.recalllawsuit.com/wp-content/uploads/iStock_insulin-pump-200x300.jpg" alt="Insulin Pump Recalls" width="200" height="300" /></a></p>
<p>A Medtronic insulin pump lawsuit was filed several months ago in November 2009 in U.S. District Court in the Southern District of Texas on behalf of diabetic patients who used the MiniMed pump. They allege they received the wrong insulin dosages and then had to be hospitalized. The plaintiffs say they were using Paradigm Quick-Set infusion sets, which are thin plastic tubes that carry the insulin from the pump to the diabetes patient. These infusion sets were supposed to work with the MiniMed pumps, but were <a href="http://www.fda.gov/MedicalDevices/Safety/RecallsCorrectionsRemovals/ListofRecalls/ucm172837.htm">recalled </a>in June 2009.  According to the FDA&#8217;s announcement:</p>
<blockquote><p>&#8220;These infusion sets may not allow the insulin pump to vent air pressure properly. This could potentially result in the device delivering too much or too little insulin and may cause serious injury or death.&#8221;</p></blockquote>
<p>However, FDA staff said in reports from the March 5 meeting that &#8220;device problems critical to insulin pumps exist across manufacturers.&#8221; After the meeting, the panel recommended that insulin pump manufacturers, such as Medtronic, Roche Holding AG, Abbott Laboratories, Hospira Inc. and Johnson &amp; Johnson, include more information when reporting potential insulin pump problems, according to <a href="http://www.nasdaq.com/aspx/company-news-story.aspx?storyid=201003051604dowjonesdjonline000617&amp;title=fda-panelmore-data-could-find-causes-of-insulin-pump-problems">news reports</a>. This could help trace the sources of insulin pump problems, the panel reported.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.recalllawsuit.com/2010/03/fda-addresses-increased-insulin-pump-recalls/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ViperSheath Catheter Sheath Recall</title>
		<link>http://www.recalllawsuit.com/2009/12/vipersheath-catheter-sheath-recall/</link>
		<comments>http://www.recalllawsuit.com/2009/12/vipersheath-catheter-sheath-recall/#comments</comments>
		<pubDate>Thu, 10 Dec 2009 21:58:46 +0000</pubDate>
		<dc:creator>Kathy Will</dc:creator>
				<category><![CDATA[Medical]]></category>

		<guid isPermaLink="false">http://www.recalllawsuit.com/?p=19</guid>
		<description><![CDATA[<p>St. Paul, Minn.-based Cardiovascular Systems, Inc. (CSI) is  recalling all lots of the ViperSheath<sup>TM</sup>Sheath Introducer after  reports of the devices fracturing and stretching, the U.S. Food and Drug  Administration <a title="blocked::http://www.fda.gov/Safety/Recalls/ucm190879.htm" href="http://www.fda.gov/Safety/Recalls/ucm190879.htm">announced</a> Monday.  Developed and manufactured by Thomas Medical Products,&#8230;</p>]]></description>
			<content:encoded><![CDATA[<p>St. Paul, Minn.-based Cardiovascular Systems, Inc. (CSI) is  recalling all lots of the ViperSheath<sup>TM</sup>Sheath Introducer after  reports of the devices fracturing and stretching, the U.S. Food and Drug  Administration <a title="blocked::http://www.fda.gov/Safety/Recalls/ucm190879.htm" href="http://www.fda.gov/Safety/Recalls/ucm190879.htm">announced</a> Monday.  Developed and manufactured by Thomas Medical Products, Inc. and distributed by  CSI, the catheter sheaths facilitate entry of an intravascular device through  the skin. A device fracture may require unplanned open surgery to remove sheath  segments or control bleeding. CSI has received three reports of ViperSheath  complications related to this recall.</p>
<p>The devices were distributed from March to  October 2009 and include lot numbers S28117 through S29174 and the following  catalog numbers: VPR-ISH 5 X 85, VPR-ISH 6 X 85, VPR-ISH 7 X 85, VPR-ISH 5 X 45,  VPR-ISH 6 X 45, VPR-ISH 7 X 45.</p>
<p>CSI has notified all customers of the recall and  is arranging for the return of all products.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.recalllawsuit.com/2009/12/vipersheath-catheter-sheath-recall/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
